Wednesday, June 19, 2024
HomeEconomyResearch: Evotec and Bristol-Myers Squibb Expand Collaboration

Research: Evotec and Bristol-Myers Squibb Expand Collaboration

Research
Evotec and Bristol-Myers Squibb Expand Collaboration

Pharmaceutical researcher Evotec and US drugmaker Bristol-Myers Squibb are expanding their partnership. The Hamburg-based group said Tuesday that the collaboration on targeted protein degradation, which began in 2018, will be extended and expanded for another eight years. Evotec will receive a down payment of US$200 million (€190 million) and also expect payments based on success. The company estimated the total potential size at 5 billion dollars. In addition, Evotec will receive multi-tiered royalties based on product sales. Share of Evotec, which has come under heavy pressure in recent months, rose a good 7 percent after the announcement.

Pharmaceutical researcher Evotec and US drugmaker Bristol-Myers Squibb are expanding their partnership. The Hamburg-based group said Tuesday that the collaboration on targeted protein degradation, which began in 2018, will be extended and expanded for another eight years. Evotec will receive a down payment of US$200 million (€190 million) and also expect payments based on success. The company estimated the total potential size at 5 billion dollars. In addition, Evotec will receive multi-tiered royalties based on product sales. Share of Evotec, which has come under heavy pressure in recent months, rose a good 7 percent after the announcement.

dpa

See also  Wassili Papas on the magic of mRNA, lessons for "Generation Share" and surprise BMW Podcast
Zoe Barker
Zoe Barker
"Writer. Analyst. Avid travel maven. Devoted twitter guru. Unapologetic pop culture expert. General zombie enthusiast."
RELATED ARTICLES

Leave a reply

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments